[Congressional Record Volume 171, Number 34 (Thursday, February 20, 2025)]
[Senate]
[Page S1174]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 306. Mr. WYDEN (for himself and Ms. Hirono) submitted an amendment 
intended to be proposed by him to the concurrent resolution S. Con. 
Res. 7, setting forth the congressional budget for the United States 
Government for fiscal year 2025 and setting forth the appropriate 
budgetary levels for fiscal years 2026 through 2034; which was ordered 
to lie on the table; as follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO 
                   PRESERVING AND ENSURING CURRENT FEDERALLY 
                   APPROVED ACCESS TO MIFEPRISTONE.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     preserving and ensuring current federally approved access to 
     mifepristone by the amounts provided in such legislation for 
     those purposes, provided that such legislation would not 
     increase the deficit over the period of the total of fiscal 
     years 2025 through 2034.
                                 ______